July 16, 2024 The Animal Health Institute (AHI) commends the Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM) for its decisive action in clarifying the prioritization of approved pioneer and generic products by veterinarians and pharmacists before considering compounded or illegally imported products. The use of FDA-approved animal drug products should always be preferred. These […]
The Animal Health Institute’s Board of Directors today elected Ester Banque of Zoetis as Board Chair for the 2024-26 term. Banque is Executive Vice President and President, U.S. Operations for Zoetis.
AHI encourages Arizona Governor Katie Hobbs to veto SB 1146, a bill that disparages life-saving vaccine technology by allowing food products from aquaculture, livestock, and poultry to be labeled “mRNA free” if the animals did not receive mRNA vaccinations.
AHI welcomes the announcement of the Food and Drug Administration’s (FDA) action to issue warning letters to nine manufacturers and distributors who were marketing unapproved and misbranded antimicrobial animal drugs.
The Animal Health Institute today praised Congress for passing the reauthorization of the Animal Drug User Fee Act (ADUFA). ADUFA provides the Food and Drug Administration’s Center for Veterinary Medicine (CVM) with supplemental industry funds in exchange for meeting agreed-upon performance goals.
CDC data reveals that an aggressive tick may be the culprit in the increased instances of alpha-gal syndrome, or red-meat allergy, a potentially life-threatening condition that affects up to 450,000 people in the U.S. Carried by the lone star tick, those with red-meat allergy have reactions to meat such as beef, pork, and lamb. The […]
Washington, D.C. – March 30, 2023. The Animal Health Institute (AHI) joined veterinary medical experts to present testimony before the House Energy and Commerce Committee on the reauthorization of the Animal Drug User Fee Act (ADUFA). Dr. Rachel Cumberbatch, AHI Director of International and Regulatory Affairs, urged Congress to swiftly reauthorize the bill that enables […]
January 31, 2023 The Animal Health Institute supports the restructuring announced by Food and Drug Commissioner Robert M. Califf. The new structure maintains the Center for Veterinary Medicine (CVM) as a stand-alone center while coordinating its food safety activities with the new Deputy Commissioner for Human Foods. “This is a practical and common-sense approach that […]
A new study from NDP Analytics, The Economic and Social Contributions of the Animal Health Industry, details the growth of the animal health industry over the past three years and documents the value and role that the companies that produce animal medicines play in the U.S. economy and beyond. As other industries struggled because of […]
The Animal Health Institute is grateful that Congress has reauthorized the Pesticide Registration Improvement Act (PRIA 5) by including it in the Consolidated Appropriations Act, 2023. PRIA provides necessary resources to the United States Environmental Protection Agency’s (EPA) Office of Pesticide Programs (OPP). The legislation will supplement annual appropriations for OPP with additional funding from […]
The Animal Health Institute (AHI) represents the companies that develop and produce animal medicines. Our industry is a global leader whose products improve the health of nearly 10 billion companion and food-producing animals in the U.S., which results in significant economic and social benefits for Americans.
Enter your account data and we will send you a link to reset your password.
Here you'll find all collections you've created before.